Caseous lymphadenitis, commonly abbreviated as CL and also known as cheesy gland disease, is a chronic bacterial infection primarily affecting sheep and goats worldwide. This condition is caused by the bacterium Corynebacterium pseudotuberculosis, which targets the lymphatic system and creates characteristic abscesses in lymph nodes and internal organs. The disease derives its name from the caseous, or cheese-like, appearance of the thick, greenish-white purulent material contained within the abscesses. CL represents one of the most economically significant and management-challenging diseases affecting small ruminant production globally.
The condition affects sheep and goat populations on every continent where these animals are raised, with prevalence rates varying widely depending on management practices and control efforts. In some extensively managed flocks and herds, infection rates may exceed 50% of the population, while well-managed operations with aggressive control programs may maintain prevalence below 5%. The disease affects animals of all ages, though clinical signs typically appear in adults as the slow-developing abscesses reach detectable size. Both meat and fiber production are impacted, making CL a concern across all sectors of the small ruminant industry.
The economic impact of caseous lymphadenitis is substantial and multifaceted. Direct losses include carcass condemnation at slaughter due to abscess contamination, reduced weight gain in affected animals, decreased wool and fiber production and quality, reduced milk production in dairy goats, and premature culling of breeding stock. Indirect costs include the extensive labor required for identification and management of affected animals, costs of vaccination programs, and the significant challenges CL poses for seedstock producers whose reputation depends on selling disease-free animals. The chronic nature of the disease and difficulty of eradication make it an ongoing management burden.
Control of caseous lymphadenitis rather than individual animal cure represents the realistic management goal for most operations. Once an animal is infected, the bacteria persist within abscesses that are effectively walled off from the immune system and antibiotics. While individual abscesses may resolve, new ones typically develop over time. Prevention through vaccination, biosecurity, and careful management of affected animals forms the cornerstone of CL control. Early detection, isolation of clinical cases, and strategic culling decisions help reduce transmission within and between flocks. Understanding the epidemiology and transmission dynamics of CL is essential for implementing effective control measures.
